{
  "paper_id": "687d11c75e96fdb573a27b6ac0ec3802de6de48a",
  "metadata": {
    "title": "Cost-Benefit of Stockpiling Drugs for Influenza Pandemic",
    "coda_data_split": "train",
    "coda_paper_id": 8436,
    "coda_has_expert_labels": false,
    "subset": "custom_license"
  },
  "abstract": [
    {
      "original_text": "We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients\u0027 close contacts.",
      "sentences": [
        [
          {
            "segment_text": "We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "including therapeutic treatment of patients and postexposure prophylactic treatment of patients \u0027 close contacts .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "1",
    "sentence_num": "2",
    "segment_num": "3",
    "token_num": "54"
  }
}